Memorial Sloan Kettering Cancer Center

Basking Ridge, NJ

Accepting patients

Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
Learn more
  • Maintenance

Accepting patients

NUTRIVENTION-4

A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide
Learn more
  • Monoclonal Antibody
  • CD38
  • Maintenance
  • Phase 2
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials

Not yet accepting

MagnetisMM-30

A Phase 1B, Open-Label Study of Elranatamab in Combination with Iberdomide in Participants with Relapsed Refractory Multiple Myeloma
Learn more
  • Bispecific Antibody
  • BCMA
  • CD3
  • Phase 1

Accepting patients

Identifying Barriers to Cellular Therapy

Prospective Multi-Center Study to Identify Barriers to Cellular Therapies in Patients With Plasma Cell Disorders PROACT PCD
Learn more
  • Observational Trial

Accepting patients

Genetic Studies

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Learn more